47M, trading at $6.95 on the NASDAQ. This SniperIQ fundamentals page covers CapsoVision's valuation, profitability (net margin -198.9%), revenue (

What is CapsoVision's P/E ratio?

CapsoVision's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 16.3x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is CapsoVision?

CapsoVision runs a net profit margin of -198.9%, a gross margin of 51.7%, and an operating margin of -11.0%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does CapsoVision generate?

CapsoVision reported revenue of

Does CapsoVision pay a dividend?

CapsoVision does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is CapsoVision financially healthy?

CapsoVision carries a debt-to-equity ratio of 0.04x and a current ratio of 4.57x, with a market beta of -2.66. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is CapsoVision a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For CapsoVision (CV) the key facts are: market cap

47M, revenue

Track CapsoVision's full fundamentals live

Get CapsoVision's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.